Long-Term Cardiovascular Safety of Febuxostat Compared With Allopurinol in Patients With Gout
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Cardiovascular Safety of Febuxostat Compared With Allopurinol in Patients With Gout (FAST): A Multicentre, Prospective, Randomised, Open-Label, Non-Inferiority Trial
Lancet 2020 Nov 06;[EPub Ahead of Print], IS Mackenzie, I Ford, G Nuki, J Hallas, CJ Hawkey, J Webster, SH Ralston, M Walters, M Robertson, R De Caterina, E Findlay, F Perez-Ruiz, JJV McMurray, TM MacDonaldFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.